Restricting Protein May Trigger a Body-Wide Program Linked to Longer Life, Researchers Propose

A new perspective paper from LSU's Pennington Biomedical Research Center proposes that restricting dietary protein may promote healthy aging through a coordinated, body-wide physiological response — not simply through isolated cellular effects. The paper, published in the journal Cell Metabolism, was authored by Dr. Chris Morrison, Dr. Sora Kim and Dr. Sangho Yu of Pennington Biomedical.

Protein restriction is increasingly recognised as a potential driver of longevity independent of calorie restriction, with lifespan-extending effects demonstrated across multiple species. Much aging research focuses on the "Hallmarks of Aging," a set of 12 cellular processes linked to aging that represent targets for anti-aging therapies. Recent studies show protein restriction affects several of these hallmarks while extending lifespan in model organisms, but most hallmarks describe specific cellular processes rather than whole-body responses.

"The question that drives our work is deceptively simple: how does an animal know it isn't getting enough protein?" said Dr. Morrison, a professor in nutritional neuroscience at Pennington Biomedical. "After years of work, we now believe the brain plays a critical role in coordinating the body's response to protein restriction, and that these same adaptive changes turn out to extend lifespan."

Pennington's Neurosignaling Laboratory has studied how organisms adaptively change growth, food preferences and metabolism when protein availability falls. That work led to the discovery that the hormone FGF21 acts in the brain to help coordinate the body's response to protein scarcity, and is required for protein restriction's effects on lifespan, metabolism and food preferences. Similar mechanisms exist in other species — in fruit flies, gut-derived signals communicate nutritional status to the brain, affecting both food preferences and longevity.

The authors argue that cellular nutrient sensing, hormone signalling, neural circuits and tissue physiology should be understood as components of one coordinated system, rather than isolated pathways. They suggest measurable changes — such as FGF21 responsiveness or shifts in protein appetite — could eventually serve as biomarkers of how effectively this adaptive program has been engaged, potentially explaining why people respond differently based on sex, genetics, age and metabolic health.